课题基金 / 基金详情

The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors

The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors
肺癌幸存者的躯体焦虑和担忧的日常经历
批准号:
7879456
负责人:
Keith Robert Aronson
金额:
$7.58万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2012-06-30

项目摘要

项目成果

Keith Robert Aronson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 肺癌幸存者的躯体焦虑和担忧的日常体验几乎所有的癌症幸存者都报告说,他们对自己的健康状况经历了令人痛苦的认知和情绪反应(例如,焦虑、担忧、恐惧),特别是在出院后。躯体焦虑和焦虑(SAW)对生活质量有不利影响。虽然SAW在癌症幸存者中普遍存在,但对于加剧或减弱这种现象的程度的因素,人们几乎一无所知。本研究在症状知觉的认知心理学模型中对SAW的体验进行了框定。具体地说,该模型预测SAW的日常体验与(A)内部集中注意调节,(B)躯体归因风格,(C)躯体症状,(D)神经质,和(E)日常应激有关。参与者将是在宾夕法尼亚州立癌症研究所看到的成年(18岁以上)、非小细胞肺癌幸存者,处于第一或第二阶段,治疗出院后最少60天,最多24个月。参与者将完成一系列简短的措施,然后将在连续八个晚上被要求完成一次简短的电话采访。在采访中,参与者将被问及当天的紧张经历、经历的躯体症状以及任何伴随而来的感受。将使用结构方程模型来评估解释SAW的模型的拟合优度。这项研究还将研究对SAW最具预测性和最不具预测性的压力体验的种类,并确定一天的体验对随后几天的SAW体验的影响程度。最后,我们将确定某一天的SAW水平对随后几天的躯体症状、压力和SAW的影响程度。最终,这项研究的目标是开发一种经验性支持的心理社会预防/干预方法,以应对癌症幸存者的SAW。基础研究成果应可直接转化为癌症幸存者经历SAW的心理社会预防/干预策略,并为SAW的其他基础和应用研究提供动力。 公共卫生相关性:这项研究将首次揭示肺癌幸存者的躯体焦虑和担忧(SAW)的日常表现。通过调查肺癌幸存者中SAW的预测因素,我们的结果将为预防和干预工作提供信息,以改善肺癌幸存者以及其他预期寿命相对较短的幸存者的生活质量。
英文摘要
DESCRIPTION (provided by applicant): The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors Virtually all cancer survivors report experiencing distressing cognitive and emotional reactions (e.g., anxiety, worry, fear) to the status of their health, particularly after discharge from treatment. Somatic anxiety and worry (SAW) has a detrimental impact on quality of life. While SAW is ubiquitous in cancer survivors, virtually nothing is known about the factors that exacerbate or diminish the degree to which the phenomenon is experienced. The research undertaken in this study frames the experience of SAW within a cognitive psychological model of symptom perception. Specifically, the model predicts that the daily experience of SAW is related to (a) internally focused attention regulation, (b) a somatic attributional style, (c) somatic symptoms, (d) neuroticism, and (e) daily stress. Participants will be adult (18 years+), non-small cell, lung cancer survivors seen at the Penn State Cancer Institute, at either Stage 1 or 2, and are a minimum of 60- days, and a maximum of 24-months, post-discharge from treatment. Participants will complete a brief battery of measures and will then be called over eight consecutive evenings to complete a brief telephone interview. During the interview, participants will be asked about the day's stressful experiences, somatic symptoms experienced, and any concomitant SAW. The goodness of fit of the model explaining SAW will be assessed using structural equation modeling. The study will also examine the kinds of stress experiences that are most and least predictive of SAW, and determine the degree to which one day's experiences influence the degree to which SAW is experienced on subsequent days. Finally, we will determine the degree to which the level of SAW on one day influences the number of somatic symptoms, stress, and SAW experienced on subsequent days. Ultimately, the goal of this research is to develop an empirically supported psychosocial prevention/intervention approach to SAW with cancer survivors. The basic research findings should be directly translatable to psychosocial prevention/intervention strategies with cancer survivors experiencing SAW, as well as provide an impetus for additional basic and applied research on SAW. PUBLIC HEALTH RELEVANCE: This study will be the first to shed light on the day-to-day manifestation of somatic anxiety and worry (SAW) in lung cancer survivors. By investigating the predictors of SAW in lung cancer survivors, our results will inform prevention and intervention efforts to improve the quality of life of lung cancer survivors, as well as other survivors with relatively short projected life spans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOMATIC ANXIETY & DISTRESS: A STRESS-DIATHESIS MODEL IN CANCER SURVIVORS
The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors
国内基金
海外基金
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
  • 批准号:
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2024
  • 负责人:
    冯锋
  • 依托单位:
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷 吐星酸酯类成分的发现及作用机制研究
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
  • 批准号:
    22367005
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    董永喜
  • 依托单位: